Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: Autoimmunity. 2009 Sep;42(6):515–524. doi: 10.1080/08916930902911738

Table II.

Performance of ELISA and/or LIPS for the diagnosis of primary SjS.

Test Sensitivity Specificity
ELISA
    SSA (Ro52 and Ro60)* 72% (41/57)
    SSB (La) 46% (26/57)
    SSA & SSB 77% (44/57)
LIPS
    La (mean plus 3 SD) 75% (43/57) 100%
    La (mean plus 5 SD) 72% (41/57) 100%
    Ro52 (mean plus 3 SD) 61% (35/57) 96%
    Ro52 (mean plus 5 SD) 60% (34/57) 100%
    Ro60 (mean plus 3 SD) 63% (36/57) 96%
    Ro60 (mean plus 5 SD) 61% (35/57) 100%
    Ro52 & Ro60 (mean plus 3 SD) 68% (39/57) 92%
    Ro52 & Ro60 (mean plus 5 SD) 68% (39/57) 100%
    La & Ro52 (mean plus 3 SD) 77% (44/57) 96%
    La & Ro52 (mean plus 5 SD) 74% (42/57) 100%
    TPO (mean plus 3 SD) 14% (8/57) 100%
    TPO (mean plus 5 SD) 11% (6/57) 100%
    H + /K + ATPase (mean plus 3 SD) 16% (9/57) 96%
    H + / K + ATPase (mean plus 5 SD) 14% (8/57) 100%
    AQP-4 (mean plus 3 SD) 12% (7/57) 100%
    AQP-4 (mean plus 5 SD) 11% (6/57) 100%
    La, Ro52, TPO & AQP-4 (mean plus 3 SD) 86% (49/57) 96%
    La, Ro52, TPO & AQP-4 (mean plus 5 SD) 79% (45/57) 100%
*

Includes 1 ELISA borderline positive cases.;

Includes 3 ELISA borderline positive case.;

Includes 2 ELISA borderline positive case.;

For LIPS, the cut-off limit for calculating sensitivity and specificity for each antigen was derived from the value of the mean plus 3 or 5 SDs of the 25 control samples.